Journal for ImmunoTherapy of Cancer (Nov 2021)
71 Tumors with higher heterogeneity were associated with superior survival outcome amongst stage I lung cancer patients with low tumor mutational burden (TMB)
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2021)